Mitchell Shawnte
CHIEF LEGAL OFFICER
Mitchell Shawnte has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, Mitchell Shawnte is listed as CHIEF LEGAL OFFICER at Olema Pharmaceuticals, Inc. Inside the rolling window, Mitchell Shawnte reported no open-market purchases and 2 open-market sales totaling $952K in OLMA. The largest disclosed transaction in the window is a sale of 25,000 OLMA shares on Mar 4, 2026, worth $606K.
Companies traded
Other insiders at OLMA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$952K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Mitchell Shawnte made?
Mitchell Shawnte has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company since 2026.
Which companies does Mitchell Shawnte trade?
Mitchell Shawnte has filed SEC Form 4 disclosures for 1 company, including OLMA.
When was Mitchell Shawnte's most recent SEC Form 4 filing?
Mitchell Shawnte's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is Mitchell Shawnte's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Mitchell Shawnte is listed as CHIEF LEGAL OFFICER.
What is Mitchell Shawnte's total buy and sell value in the current window?
Inside the rolling retention window, Mitchell Shawnte bought $0 and sold $952K based on SEC Form 4 filings.
What was Mitchell Shawnte's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 OLMA shares on 2026-03-04, worth $606K, per SEC Form 4 filings.